DCF — WELIA HEALTH
Enterprise Value: $-9.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-9.7M
Enterprise Value
$-5.8M
PV of Cash Flows
$-3.9M
PV of Terminal Value
$-6.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $109.9M | $1.7M | 2.0% | $-2.9M | $-2.7M |
| Year 2 | $113.2M | $2.9M | 3.0% | $-1.9M | $-1.6M |
| Year 3 | $116.6M | $4.2M | 4.0% | $-1.1M | $-0.8M |
| Year 4 | $120.1M | $4.9M | 4.0% | $-0.7M | $-0.5M |
| Year 5 | $123.7M | $5.3M | 4.0% | $-0.5M | $-0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-9.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$106.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.010696375418495609
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5